An open label, dose response study to determine the effect of a dietary supplement on dihydrotestosterone, testosterone and estradiol levels in healthy males

Journal of the International Society of Sports Nutrition

Volumn 5, Issue , 2008, Pages

  Angwafor III, Fru ^a   Anderson, Mark L ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Triarco Industries Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMATOCOCCUS PLUVIALIS; SABAL; SERENOA REPENS;

EID: 50649114477     PISSN: None     EISSN: 15502783     Source Type: Journal    
DOI: 10.1186/1550-2783-5-12     Document Type: Article

References (14)

1. Morimoto I Edmiston A Horton R Alteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasia J Clin Invest 1980, 66(3):612-615 371692 6156957 10.1172/JCI109895
2. Vermeulen A Clinical review 24: Androgens in the aging male J Clin Eendocrinol Metab 1991, 73(2):221-224
3. Nieschlag E Swerdloff R Behre HM Gooren LJ Kaufman JM Legros JJ Lunenfeld B Morely JE Schulman C Wang C Weidner W Wu FC Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations J Androl 2006, 27(2):135-137 10.2164/ jandrol.05047 16474020
4. Hong BS Ahn TY Recent trends in the treatment of testosterone deficiency syndrome Int J Urology 2007, 14:981-985 10.1111/j.1442-2042.2007.01882.x
5. Wang C Swerdloff R Editorial: Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause? J Clin Endocrinol Metab 2002, 87(4):1462-1466 10.1210/jc.87.4.1462 11932265
6. Chen J Kim J Dalton JT Discovery and therapeutic promise of selective androgen receptor modulators Mol Interv 2005, 5(3):173-188 2072877 15994457 10.1124/mi.5.3.7
7. Walrand S Boirie Y Optimizing protein intake in aging. Current opinion Clin Nut Met Care 2005, 8:89-94 10.1097/00075197-200501000-00014
8. Movérare-Skrtic S Venken K Andersson N Lindberg MK Svensson J Swanson C Vanderschueren D Oscarsson J Gustafsson JA Ohlsson C Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice Obesity Research 2006, 14(4):662-672 10.1038/oby.2006.75
9. Montie JE Pienta KJ Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer Urology 1994, 43(6):892-895 10.1016/0090-4295(94)90163-5 7515207
10. Strauch G Perles P Vergult G Gabriel M Gibelin B Cummings S Malbecq W Malice MP Comparison of finasteride (Proscar) and serenoa repens Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers Eur Urol 1994, 26:247-252 7805711
11. Staiman VR Lowe FC Tamoxifen for flutamide/finasteride-induced gynecomastia Urology 1997, 50(6):929-933 10.1016/S0090-4295(97)00457-3 9426725
12. Anderson ML A preliminary investigation of the enzymatic inhibition of 5α-reductase and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and saw palmetto lipid extract in vitro J Herbal Pharm 2005, 5(1):17-26 10.1300/J157v05n01_03
13. Anderson ML Method of inhibiting aromatase with specific dietary supplements U.S. Patent application # 20040156926, 2004 Triarco Industries, Inc
14. Morley JE Kaiser F Raum WJ Perry RH Flood JF Jensen J Silver AJ Roberts E Potentially predictive and manipulatable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone Proc Natl Acad Sci USA 1997, 94:7537-7542 23857 9207127 10.1073/pnas.94.14.7537